Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and nec (Q36311491)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and nec	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and nec (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

phase III clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

Mitchell Machtay

4

object named as

Mitchell Machtay

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

object named as

K Kian Ang

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

George Shenouda

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Qiang Zhang

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Matthew B Parliament

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Diane Hershock

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mohan Suntharalingam

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Alexander Lin

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Marvin Rotman

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Abdenour Nabid

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Susan Hong

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sarwat Shehata

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Anthony J Cmelak

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Khalil Sultanem

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Quynh-Thu Le

15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

7 February 2015

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

91

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

907-915

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Impact of hemoglobin levels on tumor oxygenation: the higher, the better?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

30 September 2017

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

29 June 2018

Erythropoietin regulates tumour growth of human malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

29 June 2018

Erythropoietin and erythropoietin receptor expression in human cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

29 June 2018

Recombinant human erythropoietin in the treatment of the anaemia of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

29 June 2018

VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

22 September 2018

Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

22 September 2018

Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

22 September 2018

Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

22 September 2018

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4657552

22 September 2018

Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25670542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin stimulates proliferation of human renal carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25670542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25670542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25670542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25670542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem-like Cells to Protect Them from Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25670542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2014.12.018

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36311491&oldid=2109523596"